Food Allergy: an Overview
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
The Safety Evaluation of Food Flavouring Substances
Toxicology Research View Article Online REVIEW View Journal The safety evaluation of food flavouring substances: the role of metabolic studies Cite this: DOI: 10.1039/c7tx00254h Robert L. Smith,a Samuel M. Cohen, b Shoji Fukushima,c Nigel J. Gooderham,d Stephen S. Hecht,e F. Peter Guengerich, f Ivonne M. C. M. Rietjens,g Maria Bastaki,h Christie L. Harman,h Margaret M. McGowenh and Sean V. Taylor *h The safety assessment of a flavour substance examines several factors, including metabolic and physio- logical disposition data. The present article provides an overview of the metabolism and disposition of flavour substances by identifying general applicable principles of metabolism to illustrate how information on metabolic fate is taken into account in their safety evaluation. The metabolism of the majority of flavour substances involves a series both of enzymatic and non-enzymatic biotransformation that often results in products that are more hydrophilic and more readily excretable than their precursors. Flavours can undergo metabolic reactions, such as oxidation, reduction, or hydrolysis that alter a functional group relative to the parent compound. The altered functional group may serve as a reaction site for a sub- sequent metabolic transformation. Metabolic intermediates undergo conjugation with an endogenous agent such as glucuronic acid, sulphate, glutathione, amino acids, or acetate. Such conjugates are typi- Received 25th September 2017, cally readily excreted through the kidneys and liver. This paper summarizes the types of metabolic reac- Accepted 21st March 2018 tions that have been documented for flavour substances that are added to the human food chain, the DOI: 10.1039/c7tx00254h methodologies available for metabolic studies, and the factors that affect the metabolic fate of a flavour rsc.li/toxicology-research substance. -
Food Allergy Outline
Allergy Evaluation-What it all Means & Role of Allergist Sai R. Nimmagadda, M.D.. Associated Allergists and Asthma Specialists Ltd. Clinical Assistant Professor Of Pediatrics Northwestern University Chicago, Illinois Objectives of Presentation • Discuss the different options for allergy evaluation. – Skin tests – Immunocap Testing • Understand the results of Allergy testing in various allergic diseases. • Briefly Understand what an Allergist Does Common Allergic Diseases Seen in the Primary Care Office • Atopic Dermatitis/Eczema • Food Allergy • Allergic Rhinitis • Allergic Asthma • Allergic GI Diseases Factors that Influence Allergies Development and Expression Host Factors Environmental Factors . Genetic Indoor allergens - Atopy Outdoor allergens - Airway hyper Occupational sensitizers responsiveness Tobacco smoke . Gender Air Pollution . Obesity Respiratory Infections Diet © Global Initiative for Asthma Why Perform Allergy Testing? – Confirm Allergens and answer specific questions. • Am I allergic to my dog? • Do I have a milk allergy? • Have I outgrown my allergy? • Do I need medications? • Am I penicillin allergic? • Do I have a bee sting allergy Tests Performed in the Diagnostic Allergy Laboratory • Allergen-specific IgE (over 200 allergen extracts) – Pollen (weeds, grasses, trees), – Epidermal, dust mites, molds, – Foods, – Venoms, – Drugs, – Occupational allergens (e.g., natural rubber latex) • Total Serum IgE (anti-IgE; ABPA) • Multi-allergen screen for IgE antibody Diagnostic Allergy Testing Serological Confirmation of Sensitization History of RAST Testing • RAST (radioallergosorbent test) invented and marketed in 1974 • The suspected allergen is bound to an insoluble material and the patient's serum is added • If the serum contains antibodies to the allergen, those antibodies will bind to the allergen • Radiolabeled anti-human IgE antibody is added where it binds to those IgE antibodies already bound to the insoluble material • The unbound anti-human IgE antibodies are washed away. -
Allergen Regulations 105 Cmr 590.000
ALLERGEN REGULATIONS 105 CMR 590.000: STATE SANITARY CODE CHAPTER X – MINIMUM SANITATION STANDARDS FOR FOOD ESTABLISHMENTS (1) ADD new definition in 105 CMR 590.002(B): Major Food Allergen means: (1) Milk, eggs, fish (such as bass, flounder, or cod), crustaceans (such as crab, lobster, or shrimp), tree nuts (such as almonds, pecans, or walnuts), wheat, peanuts, and soybeans; and (2) A FOOD ingredient that contains protein derived from a FOOD named in subsection (1). "Major food allergen" does not include: (a) Any highly refined oil derived from a FOOD specified in subsection (1) or any ingredient derived from such highly refined oil; or (b) Any ingredient that is exempt under the petition or notification process specified in the federal Food Allergen Labeling and Consumer Protection Act of 2004 (Public Law 108-282). (2) Amend the definitions of “menu” and “menu board” in 590.002(B) as follows: Menu means a printed list or pictorial display of a food item or items and their price(s) that are available for sale from a food establishment, and includes menus distributed or provided outside of the establishment. Menu Board means any list or pictorial display of a food item or items and their price(s) posted within or outside a food establishment. (3) Amend as follows 105 CMR 590.003(B) (Management and Personnel – federal 1999 Food Code Chapter 2) (B) FC 2-102.11 Demonstration … The areas of knowledge include: . (17) No later than February 1, 2011: (a) Describing FOODS identified as MAJOR FOOD ALLERGENS and describing the symptoms that MAJOR FOOD ALLERGENS could cause in a sensitive individual who has an allergic reaction; and (b) Ensuring that employees are properly trained in food allergy awareness as it relates to their assigned duties. -
Food Allergen Labeling Exemption Petitions and Notifications: Guidance for Industry
Contains Nonbinding Recommendations Food Allergen Labeling Exemption Petitions and Notifications: Guidance for Industry Additional copies are available from: Office of Food Additive Safety, HFS-205 Center for Food Safety and Applied Nutrition Food and Drug Administration 5001 Campus Drive College Park, MD 20740 (Tel) 240-402-1200 http://www.fda.gov/FoodGuidances You may submit either electronic or written comments regarding this guidance at any time. Submit electronic comments to http://www.regulations.gov. Submit written comments on the guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that publishes in the Federal Register. U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition June 2015 Petitions and Notifications Guidance Page 1 of 18 Contains Nonbinding Recommendations Table of Contents I. Introduction II. Statutory Authority III. Recommendations for Preparing Submissions IV. Additional Information for Petitions V. Additional Information for Notifications VI. Appendices Petitions and Notifications Guidance Page 2 of 18 Contains Nonbinding Recommendations Food Allergen Labeling Exemption Petitions and Notifications Guidance for Industry This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. -
Egg Allergy: the Facts
Egg Allergy: The Facts Egg is a common cause of allergic reactions in infants and young children. It often begins in the child’s first year of life and in some cases lasts into the teenage years – or even into adulthood for a few people. Children who develop allergy to foods such as egg often have other allergic conditions. Eczema and food allergy often occur in early infancy and later on there may be hay-fever, asthma or both. This Factsheet aims to answer some of the questions which you and your family may have about living with egg allergy. Our aim is to provide information that will help you to understand and minimise risks. Even severe cases can be well managed with the right guidance. Many cases of egg allergy are mild, but more severe symptoms are a possibility for some people. If you believe you or your child is allergic to egg, the most important message is to visit your GP and ask for allergy tests and expert advice on management. Throughout this Factsheet you will see brief medical references given in brackets. If you wish to see the full references, please email us at [email protected]. Symptoms triggered by egg The symptoms of a food allergy, including egg allergy, may occur within seconds or minutes of contact with the culprit food. On occasions there may be a delay of more than an hour. Mild symptoms include nettle rash (otherwise known as hives or urticaria) or a tingling or itchy feeling in the mouth. More serious symptoms are uncommon but remain a possibility for some people, including children. -
16354 Hutch-MSD Oct03.Qxd
METABOLISM OFF-FLAVOR IN MAPLE SYRUP Part II: Remediation of metabolism off-flavor in maple syrup Abby K. van den Berg1, Timothy D. Perkins1, Mark L. Isselhardt1, Mary An Godshall2 and Steven W. Lloyd3 INTRODUCTION 'Metabolism' is an off-flavor described as 'earthy to bitter' which significantly reduces the economic value of maple syrup (Perkins et al. 2006). It periodically occurs in syrup simultaneously over a wide geographic range, and in some years can affect up to 25% of the total annual maple syrup crop (Perkins and van den Berg in press). Research on metabolism at the University of Vermont Proctor Maple Research Center (PMRC) had two main objectives: 1) to identify the primary compound or compounds responsi- ble for metabolism off-flavor in maple syrup, and 2) to develop a technique maple pro- ducers and packers could use to effectively remediate the flavor of metabolized maple syrup. The primary compound associated with metabolism off-flavor was identified as 2,5- dimethylpyrazine (2,5-DMP) (van den Berg et al. 2009a). 2,5-dimethylpyrazine is a nat- urally-occurring volatile flavor compound found in a variety of heat-processed foods, including roasted beef, cocoa, bacon, and coffee (Maga 1992), as well as maple syrup (Alli et al. 1992, Akochi-K. et al. 1997). In maple syrup with metabolism off-flavor, how- ever, 2,5-DMP occurs in much greater concentrations (up to 40 times greater) than in syrup without the off-flavor (van den Berg et al. 2009a). In practice, producers and packers attempt to blend out the off-flavor by mixing metabolized syrup in with good-tasting syrup. -
Phase I Open-Label Study of Omalizumab (Xolair) in Peanut-Allergic Patients
Kari C. Nadeau, MD, PhD Division of Allergy , Immunology, and Rheumatology at Stanford Describe the pathophysiology, initial evaluation & management of patients with food allergy including gastrointestinal food allergy, oral allergy syndrome and type I food allergy Identify recent advances in the field of food allergy and have some familiarity with published guidelines for managing food allergy Outline current and emerging treatment modalities for food allergic patients Nothing to disclose ID: 9.5 y.o. male with a history of severe food allergies, eczema, and asthma CC: Presents to PICU with hypoxic brain injury due to anaphylaxis from cow’s milk ingestion Transferred to PICU from outside hospital after multiple failed resuscitations over a 3 hr period On the evening of 8-11-04, patient accidentally drank from his sister’s cup of cow’s milk on the way to bed. He immediately developed emesis and became SOB; parents gave Epipen jr. to his thigh and called 911 Paramedics arrived in 10-15 minutes On the scene, intubation was attempted but difficult Duration of code=1 hr. CT scan showed hypoxic injury and right uncal herniation. In 2001, he presented to LPCH AAI clinic and had severe eczema and asthma. RAST tests were performed at 2001 and showed IgE > 2000, Milk> 100, Peanut>100, Egg 40.3, Soy 17.9, Wheat 20.2, Corn 26.3, Oat 12.3. No known allergies to beef. He had had one prior visit to the ER for milk ingestion in 2001. He presented with hyperventilation and emesis. He was given benadryl and his symptoms improved. -
Food Words Describing Taste and Flavor
Food Words Describing Taste and Flavor Look thorough this list and write down 15-20 you think would help your descriptive writing for your restaurant review paper. Make sure you are suing the word correctly and in its correct form. Acerbic is anything sour, bitter or sharp - cutting, caustic, acid, mordant, barbed, prickly, biting, pointed. The opposite flavor would be mild, sweet, or honeyed. Acid or Acidic food can be sharp, tart, sour, bitter. Just the opposite of sweet, sugary, honey. Acrid taste can be considered pungent, bitter, choking, sharp, unpleasant, harsh - sharp, cutting, caustic, bitter, vitriolic, mordant, trenchant - sour, tart, sharp, biting, acerbic. Aftertaste is the trace, hint, smack, relish, savor food leaves behind. Ambrosia is the food of the gods, and epicurean delight, food fit for a king, delicacy, heavenly spread, gastronomical delight, some apply this term to the pièce de résistance in a meal. Ambrosial is, therefore, fit for the gods, delectable, mouthwatering, heavenly, savory, delicious, tasty, toothsome, divine. It is not distasteful or disgusting at all. Appealing food is attractive, tempting, interesting, pleasing, alluring, likable, engaging, charming, fascinating, glamorous. It is never repulsive, disgusting, or repellent. Appetite is the hunger, craving, desire, taste, ravenousness, sweet tooth, thirst, penchant, or passion we experience. When we have an appetite for something, we don't find it repulsive or distasteful. Appetizer is the tidbit, snack, starter, hors d'oeuvre, finger food, dip, cold cuts, kickshaw, olives, anchovies - canapés, dim sum, aperitif, rollmops, antipasto, crudités we might have to open a meal. Appetizing is everything we find appealing, mouth-watering, delectable, savory, delicious, palatable, inviting, tantalizing, toothsome, luscious, tempting, tasty, enticing. -
TITLE of STUDY Milk Allergy Is a Very Common Problem in Children. Milk
TITLE OF STUDY Milk Desensitization and Induction of Tolerance in Children Milk Allergy is a very common problem in children. Milk-induced symptoms effect up-to 20% of children, with detrimental effects on nutrition during critical periods of growth. Moreover, approximately 2-5% of children make IgE antibodies against cow’s milk, which are responsible for severe allergic reactions and anaphylaxis. Milk is the second most common food causing life-threatening anaphylaxis in North America and Europe, and the most common food to cause life- threatening symptoms world-wide. Due to the ubiquitous nature of dairy products in our diet, milk is extremely difficult to avoid. Treatment of milk allergy is currently based on strict avoidance, and patients must carry injectable adrenalin (e.g. Epipen). Our study will assess a novel and potentially life-changing therapy, by actively treating milk allergy with Oral Immunotherapy. This may allow patients to safely consume dairy products. Treatment with oral-immunotherapy has been piloted in the USA and Europe, but there is no current research into milk- immunotherapy in Canada, depriving our population of a potential cure for this very common problem. We propose to perform a well-defined clinical study, using proper control groups and immunological measures to properly understand the ideal patients and the safest and most efficacious methodologies. If successful, this study will clearly increase the margin of safety for children and young adults who suffer from life-threatening milk allergy. It can also increase the consumption of dairy products within this population, providing nutritional benefits including improved bone mineralization and growth. -
Ige – the Main Player of Food Allergy
DDMOD-431; No of Pages 8 Vol. xxx, No. xx 2016 Drug Discovery Today: Disease Models Editors-in-Chief Jan Tornell – AstraZeneca, Sweden DRUG DISCOVERY Andrew McCulloch – University of California, SanDiego, USA TODAY DISEASE MODELS IgE – the main player of food allergy 1 2,3 2 Henrike C.H. Broekman , Thomas Eiwegger , Julia Upton , 4, Katrine L. Bøgh * 1 Department of Dermatology/Allergology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands 2 Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Department of Paediatrics, Hospital for Sick Children, Toronto, Canada 3 Research Institute, Physiology and Experimental Medicine, The University of Toronto, Toronto, Canada 4 National Food Institute, Technical University of Denmark, Søborg, Denmark Food allergy is a growing problem worldwide, presently Section editor: affecting 2–4% of adults and 5–8% of young children. IgE Michelle Epstein – Medical University of Vienna, is a key player in food allergy. Consequently huge Department of Dermatology, DIAID, Experimental Allergy, Waehringer Guertel 18-20, Room 4P9.02, A1090, efforts have been made to develop tests to detect Vienna, Austria. either the presence of IgE molecules, their allergen binding sites or their functionality, in order to provide allergen ingestion [1], and involve one or more of the follow- information regarding the patient’s food allergy. The ing systems; the skin (pruritus, urticaria, or angioedema), the ultimate goal is to develop tools that are capable of gastro-intestinal tract (diarrhea, vomiting, contractions, in- creased bowel movement), the respiratory tract (asthma at- discriminating between asymptomatic sensitization tack, hoarseness, stridor/laryngeal angioedema) or the and a clinically relevant food allergy, and between cardiovascular system (dizziness, drop in blood pressure, loss different allergic phenotypes in an accurate and trust- of consciousness) [2,3]. -
Allergy and Immunology Milestones
Allergy and Immunology Milestones The Accreditation Council for Graduate Medical Education Second Revision: August 2019 First Revision: August 2013 Allergy and Immunology Milestones The Milestones are designed only for use in evaluation of residents in the context of their participation in ACGME-accredited residency or fellowship programs. The Milestones provide a framework for the assessment of the development of the resident in key dimensions of the elements of physician competency in a specialty or subspecialty. They neither represent the entirety of the dimensions of the six domains of physician competency, nor are they designed to be relevant in any other context. i Allergy and Immunology Milestones Work Group Amal Assa’ad, MD Evelyn Lomasney, MD Taylor Atchley, MD Aidan Long, MD T. Prescott Atkinson, MD, PhD Mike Nelson, MD Laura Edgar, EdD, CAE Princess Ogbogu, MD Beverly Huckman, BA* Kelly Stone, MD, PhD Bruce Lanser, MD The ACGME would like to thank the following organizations for their continued support in the development of the Milestones: American Board of Allergy and Immunology American Academy of Allergy, Asthma, and Immunology Review Committee for Allergy and Immunology *Acknowledgments: The Work Group and the ACGME would like to honor Beverly Huckman, for her contributions as the non-physician member of the milestones work group. She will be greatly missed. ii Understanding Milestone Levels and Reporting This document presents the Milestones, which programs use in a semi-annual review of resident performance, and then report to the ACGME. Milestones are knowledge, skills, attitudes, and other attributes for each of the ACGME Competencies organized in a developmental framework. -
Oral Immunotherapy for Peanut Allergy: an Evidence-Based Medicine Assessment
Editorials 2. Paraskevas KI, Bessias N, Perdikides TP, Mikhailidis DP. Statins and venous infarctions induce differential lesional interleukin-16 (IL-16) expression confined to thromboembolism: A novel effect of statins? Current Medical Research and infiltrating granulocytes, CD8+ T-lymphocytes and activated Opinion 2009; 25(7):1807-09. http://dx.doi.org/10.1185/03007990903052591 microglia/macrophages. Journal of Neuroimmunology 2001;114:232-24. 3. Waters DD. Exploring new indications for statins beyond atherosclerosis: Successes http://dx.doi.org/10.1016/S0165-5728(00)00433-1 and setbacks. J Cardiol 2010;55(2):155-62. 10. Heart Stabile E, Kinnaird T, la Sala A, et al. CD8+ T Lymphocytes Regulate the http://dx.doi.org/10.1016/j.jjcc.2009.12.003 Arteriogenic Response to Ischemia by Infiltrating the Site of Collateral Vessel 4. Muscal E, Brey RL Antiphospholipid syndrome and the brain in pediatric and adult Development and Recruiting CD4 Mononuclear Cells Through the Expression of patients. Lupus 2010;19(4):406-11. http://dx.doi.org/10.1177/0961203309360808 Interleukin-16. Circulation 2006,113:118-24. 5. Pedersen TR. Pleiotropic effects of statins: evidence against benefits beyond LDL- http://dx.doi.org/10.1161/CIRCULATIONAHA.105.576702 cholesterol lowering. Am J Cardiovasc Drugs 2010;10(Suppl 10). 11. National Research Council. "10 Tobacco Smoke and Toxicology." Clearing the 6. Morales-Villegas EC, Di Sciascio G, Briguori C. Statins: Cardiovascular Risk Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of The National Academies Press, 2001.) Hyperacute Use of Statins.